Kamu erişimi zorunlu olan makaleler - Gareth BondDaha fazla bilgi edinin
Hiçbir yerde sunulmuyor: 1
Expression of microRNA 210 associates with poor survival and age of tumor onset of soft‐tissue sarcoma patients
T Greither, P Würl, L Grochola, G Bond, M Bache, M Kappler, ...
International Journal of Cancer 130 (5), 1230-1235, 2012
Zorunlu olanlar: German Research Foundation
Bir yerde sunuluyor: 30
The importance of p53 pathway genetics in inherited and somatic cancer genomes
G Stracquadanio, X Wang, MD Wallace, AM Grawenda, P Zhang, J Hewitt, ...
Nature reviews Cancer 16 (4), 251-265, 2016
Zorunlu olanlar: US National Institutes of Health
A polymorphic p53 response element in KIT ligand influences cancer risk and has undergone natural selection
J Zeron-Medina, X Wang, E Repapi, MR Campbell, D Su, F Castro-Giner, ...
Cell 155 (2), 410-422, 2013
Zorunlu olanlar: US National Institutes of Health, National Health and Medical Research …
A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development
SM Post, A Quintás-Cardama, V Pant, T Iwakuma, A Hamir, JG Jackson, ...
Cancer cell 18 (3), 220-230, 2010
Zorunlu olanlar: US National Institutes of Health
Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice
B Leroy, ML Ballinger, F Baran-Marszak, GL Bond, A Braithwaite, ...
Cancer research 77 (6), 1250-1260, 2017
Zorunlu olanlar: US National Institutes of Health
MEF2 transcription factors are key regulators of sprouting angiogenesis
N Sacilotto, KM Chouliaras, LL Nikitenko, YW Lu, M Fritzsche, ...
Genes & development 30 (20), 2297-2309, 2016
Zorunlu olanlar: UK Biotechnology and Biological Sciences Research Council, British Heart …
Venous identity requires BMP signalling through ALK3
A Neal, S Nornes, S Payne, MD Wallace, M Fritzsche, P Louphrasitthiphol, ...
Nature communications 10 (1), 453, 2019
Zorunlu olanlar: UK Biotechnology and Biological Sciences Research Council, British Heart …
Expanding horizons: new roles for non-canonical RNA-binding proteins in cancer
S Moore, AI Järvelin, I Davis, GL Bond, A Castello
Current opinion in genetics & development 48, 112-120, 2018
Zorunlu olanlar: Cancer Research UK, UK Medical Research Council, Wellcome Trust
Comprehensive landscape of active deubiquitinating enzymes profiled by advanced chemoproteomics
A Pinto-Fernández, S Davis, AB Schofield, HC Scott, P Zhang, E Salah, ...
Frontiers in chemistry 7, 592, 2019
Zorunlu olanlar: Cancer Research UK, UK Engineering and Physical Sciences Research Council …
A polymorphic enhancer near GREM1 influences bowel cancer risk through differential CDX2 and TCF7L2 binding
A Lewis, L Freeman-Mills, E de la Calle-Mustienes, RM Giráldez-Pérez, ...
Cell reports 8 (4), 983-990, 2014
Zorunlu olanlar: Cancer Research UK, UK Medical Research Council, Wellcome Trust, European …
A polymorphic antioxidant response element links NRF2/sMAF binding to enhanced MAPT expression and reduced risk of Parkinsonian disorders
X Wang, MR Campbell, SE Lacher, HY Cho, M Wan, CL Crowl, ...
Cell reports 15 (4), 830-842, 2016
Zorunlu olanlar: US National Institutes of Health
Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression, and drug response
P Zhang, I Kitchen-Smith, L Xiong, G Stracquadanio, K Brown, PH Richter, ...
Cancer research 81 (7), 1667-1680, 2021
Zorunlu olanlar: US National Institutes of Health, British Heart Foundation, Cancer Research …
A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma
KS Yee, L Grochola, G Hamilton, A Grawenda, EE Bond, H Taubert, ...
Cancer research 72 (9), 2206-2217, 2012
Zorunlu olanlar: Cancer Research UK
Genomic hallmarks and therapeutic implications of G0 cell cycle arrest in cancer
AJ Wiecek, SJ Cutty, D Kornai, M Parreno-Centeno, LE Gourmet, ...
Genome Biology 24 (1), 128, 2023
Zorunlu olanlar: UK Biotechnology and Biological Sciences Research Council, Cancer Research …
Identification and validation of a biomarker signature in patients with resectable pancreatic cancer via genome-wide screening for functional genetic variants
C Dimitrakopoulos, B Vrugt, R Flury, P Schraml, U Knippschild, P Wild, ...
JAMA surgery 154 (6), e190484-e190484, 2019
Zorunlu olanlar: Swiss Cancer Foundation
A genetic variant in a PP2A regulatory subunit encoded by the PPP2R2B gene associates with altered breast cancer risk and recurrence
A Vazquez, D Kulkarni, LF Grochola, GL Bond, N Barnard, D Toppmeyer, ...
International journal of cancer 128 (10), 2335-2343, 2011
Zorunlu olanlar: US National Institutes of Health
iASPP mediates p53 selectivity through a modular mechanism fine-tuning DNA recognition
S Chen, J Wu, S Zhong, Y Li, P Zhang, J Ma, J Ren, Y Tan, Y Wang, ...
Proceedings of the National Academy of Sciences 116 (35), 17470-17479, 2019
Zorunlu olanlar: US National Institutes of Health, National Natural Science Foundation of …
An information-theoretic analysis of genetics, gender and age in cancer patients
GS Atwal, R Rabadan, G Lozano, LC Strong, MWG Ruijs, MK Schmidt, ...
PLoS One 3 (4), e1951, 2008
Zorunlu olanlar: US National Institutes of Health
Germline pathogenic variants impact clinicopathology of advanced lung cancer
S Mukherjee, C Bandlamudi, MD Hellmann, Y Kemel, E Drill, H Rizvi, ...
Cancer Epidemiology, Biomarkers & Prevention 31 (7), 1450-1459, 2022
Zorunlu olanlar: US National Institutes of Health, LUNGevity Foundation, USA, Cancer …
Interaction between p53 mutation and a somatic HDMX biomarker better defines metastatic potential in breast cancer
AM Grawenda, EK Møller, S Lam, E Repapi, AFAS Teunisse, GIG Alnæs, ...
Cancer research 75 (4), 698-708, 2015
Zorunlu olanlar: Worldwide Cancer Research, UK
Yayıncılık ve maddi kaynak bilgileri otomatik olarak bir bilgisayar programı tarafından belirlenmektedir